Today: 2 March 2026
Subscribe
Browse Category

Stock Market 24 September 2025 - 25 September 2025

Deus Ex Remastered Announced – Iconic Cyberpunk RPG Returns to PS5 in 2026

Deus Ex Remastered Announced – Iconic Cyberpunk RPG Returns to PS5 in 2026

A full remaster of the original Deus Ex was announced for PlayStation 5, launching February 5, 2026, with no PC or Xbox versions confirmed. Aspyr and Eidos-Montréal are overhauling graphics, controls, and character models while preserving the game’s core design. Fan reactions are mixed, with some praising the update and others criticizing the visuals compared to PC mods.
25 September 2025
Tata Stock Split Frenzy: Tata Investment Shares Soar 25% in Two Days, Record Date Set – What Investors Should Know

Tata Stock Split Frenzy: Tata Investment Shares Soar 25% in Two Days, Record Date Set – What Investors Should Know

Tata Investment Corporation shares surged about 25% in two days after shareholders approved a 1:10 stock split, the first in the company’s history. The stock hit a record high of around ₹9,100 on September 24, up from ₹7,280 at the week’s start. The record date for the split is set for October 14. Anticipation of Tata Capital’s upcoming IPO also fueled investor interest.
25 September 2025
·
PlayStation State of Play Sept 2025 – Xbox Exclusive Lands on PS5, Classic Comebacks & More Shocks

PlayStation State of Play Sept 2025 – Xbox Exclusive Lands on PS5, Classic Comebacks & More Shocks

Housemarque’s Saros debuted with five minutes of gameplay and a March 20, 2026 release date. Microsoft Flight Simulator 2024 arrives on PS5 December 8, 2025, with possible PS VR2 support. Deus Ex Remastered and Dynasty Warriors 3 remaster are set for early 2026. Nioh 3, Code Vein 2, and Let It Die: Inferno received firm release dates.
25 September 2025
···
AI Data Center Boom Sends GDS Holdings Stock Soaring – 2025 Outlook Reveals What’s Next for Investors

AI Data Center Boom Sends GDS Holdings Stock Soaring – 2025 Outlook Reveals What’s Next for Investors

GDS Holdings shares jumped over 10% to above $41 on September 24, 2025, after Q2 earnings beat expectations and the company launched China’s first data center C-REIT IPO, raising RMB2.4 billion. Revenue rose 12.4% year-on-year to RMB2.90 billion, and net losses narrowed. Eight of 11 analysts now rate the stock a Buy or Strong Buy. GDS’s debt remains high despite stronger cash reserves.
24 September 2025
···
Peabody Energy’s 2025 Coal Comeback: Big Buybacks, Booming Demand, and a Surging Stock

Peabody Energy’s 2025 Coal Comeback: Big Buybacks, Booming Demand, and a Surging Stock

Peabody Energy shares jumped nearly 8% on September 24, closing around $25.71, and are up about 30–35% over the past quarter. The company canceled a $3.8 billion deal for Anglo American’s Australian coal assets in August after a mine fire. Peabody raised full-year guidance despite a Q2 loss and expanded its $1 billion buyback. Analyst price targets have climbed to $23–$24 as coal demand stays strong.
24 September 2025
··
Fluence Energy (FLNC) Skyrockets on Mega Battery Deal – Inside the Rally and What’s Next

Fluence Energy (FLNC) Skyrockets on Mega Battery Deal – Inside the Rally and What’s Next

Fluence Energy shares surged nearly 40% to $11.24 on Sept 24, 2025, after winning a 133 MW/622 MWh battery storage contract in Poland. Despite the rally, the stock remains down 39% year-to-date and well below its 52-week high. Fiscal Q3 revenue rose 25% to $602.5 million, with a $4.9 billion order backlog. Analyst sentiment is mixed, with most rating the stock “Hold” and price targets near $8–$9.
24 September 2025
··
Acadia Healthcare’s Wild 2025 Ride: Activist Investor Shake-Up, Stock Surge & Mental Health Market Frenzy

Acadia Healthcare’s Wild 2025 Ride: Activist Investor Shake-Up, Stock Surge & Mental Health Market Frenzy

Acadia Healthcare shares surged nearly 9% on September 24, 2025, after Engine Capital disclosed a 3% stake and called for board changes and asset sales. The stock’s rally followed a 70% drop from 2022 highs and a year-to-date decline of 41%. Acadia’s board hired Goldman Sachs and J.P. Morgan as advisors. Q2 revenue rose 9%, but 2025 guidance was trimmed due to high costs.
24 September 2025
·
VNET Group’s AI-Fueled Data Center Boom Sends Stock Soaring – What Investors Need to Know

VNET Group’s AI-Fueled Data Center Boom Sends Stock Soaring – What Investors Need to Know

VNET Group shares jumped 14% to $10.62 on September 24, 2025, after landing a 40MW data center contract near Beijing. Q2 revenue rose 22% to RMB 2.43 billion, but the company posted a loss of $0.06 per share, missing estimates. VNET holds RMB 17.4 billion in debt and raised $430 million in March via convertible bonds. Founder Sheng “Josh” Chen remains interim CEO after dropping a privatization plan.
24 September 2025
····
Cidara Therapeutics (CDTX) Surges on Accelerated Flu Drug Trial – Key Updates for Investors

Cidara Therapeutics (CDTX) Surges on Accelerated Flu Drug Trial – Key Updates for Investors

Cidara Therapeutics shares surged over 20% to near $88 on Sept. 24, 2025, after the FDA allowed it to accelerate Phase 3 trials for its flu drug CD388 by six months and expand the eligible population to over 100 million adults. The stock is up 173% year-to-date. Cidara raised $402.5 million in June, bringing cash reserves to $516.9 million, and now owns 100% of CD388 after ending a Janssen partnership.
24 September 2025
·
Opendoor’s Meteoric Comeback: How Meme Hype and Housing Hopes Fueled a 1600% Stock Surge

Opendoor’s Meteoric Comeback: How Meme Hype and Housing Hopes Fueled a 1600% Stock Surge

Opendoor Technologies shares surged over 1,600% from under $1 to above $10 by mid-September, then settled near $7–$8, valuing the company above $6 billion. CEO Carrie Wheeler resigned in August; Kaz Nejatian was named CEO, with Keith Rabois returning as chairman and planning major layoffs. Q2 showed positive adjusted EBITDA and narrowed losses, but Q3 guidance warns of renewed losses. Retail traders have driven extreme volatility and high trading volumes.
24 September 2025
··
uniQure (QURE) Stock Soars on Huntington’s Breakthrough – Key Facts & 2025 Outlook

Gene Therapy Breakthrough: uniQure’s QURE Stock Skyrockets on Huntington’s Triumph

uniQure shares jumped over 150% on September 24, 2025, after its Huntington’s gene therapy slowed disease progression by 75% in a landmark trial. The company’s market value rose above $2.5 billion. uniQure plans to seek FDA approval in early 2026 and secured a $175 million credit facility to support commercialization. Cash reserves reached $377 million as of June 30, 2025.
24 September 2025
····
Nasdaq’s 48-Hour Whiplash: AI Mega-Deals, Fed Curveballs & Record Highs

Nasdaq’s 48-Hour Whiplash: AI Mega-Deals, Fed Curveballs & Record Highs

The Nasdaq Composite fell about 1% on Sept. 23 after Fed Chair Jerome Powell called stock valuations “fairly highly valued” and gave no timeline for more rate cuts. Nvidia shares hit a record high after announcing up to $100 billion investment in OpenAI, while Alibaba’s U.S. shares surged 9% on increased AI spending. U.S. Treasury yields dropped midweek, and gold reached a new all-time high near $3,764 an ounce.
24 September 2025
·········
Wall Street Roiled: Fed Warning Cools Rally as AI Frenzy Ignites Stocks and Crash Fears

Wall Street Roiled: Fed Warning Cools Rally as AI Frenzy Ignites Stocks and Crash Fears

U.S. stocks ended a three-day record streak Tuesday after Fed Chair Jerome Powell warned asset prices are “fairly highly valued,” sending the S&P 500 down 0.6%. President Trump canceled budget talks with Democrats, raising shutdown risks. Nvidia fell 3% while Alibaba jumped 9% on AI news. Lithium Americas soared 89% after reports of possible U.S. investment. Oil prices hit three-week highs as inventories dropped.
24 September 2025
····
Riot Platforms (RIOT) Skyrockets as Bitcoin Booms – Latest News, Insights & Forecasts

Riot Platforms (RIOT) Skyrockets as Bitcoin Booms – Latest News, Insights & Forecasts

Riot Platforms shares jumped over 10% this week as Bitcoin topped $100,000 and the company reported record August production of 477 BTC, generating $51.8 million in revenue. Riot posted Q2 net income of $219.5 million, reversing losses, driven by a $470 million gain on Bitcoin holdings. The firm’s mining costs remain among the lowest in the sector. Short interest in Riot stock stands at about 22% of float.
24 September 2025
···
Bitcoin Miner to AI Cloud Sensation: Why Iris Energy (IREN) Stock Is Soaring in 2025

Bitcoin Miner to AI Cloud Sensation: Why Iris Energy (IREN) Stock Is Soaring in 2025

Iris Energy (NASDAQ: IREN) traded near $47 intraday Sept. 24, up 13% on heavy volume, after doubling AI cloud capacity to 23,000 GPUs and targeting over $500 million in annualized cloud revenue by Q1 2026. Shares have surged 50% in a week and 269% year-to-date, with market cap above $10 billion. FY2025 revenue hit $501 million, net income $86.9 million, aided by Bitcoin’s rise to $113,000.
24 September 2025
····
ServiceNow’s AI Revolution: Record Growth, Stock Insights & Bold Moves in 2025

ServiceNow’s AI Revolution: Record Growth, Stock Insights & Bold Moves in 2025

ServiceNow reported Q2 2025 subscription revenue of $3.11 billion, up 22.5% year-over-year. Shares trade in the mid-$900s, down about 12% in 2025, with a market cap near $200 billion. The company launched its “Zurich” AI platform in September and secured a major federal IT deal with the U.S. GSA. Morgan Stanley upgraded the stock to “Overweight” with a $1,250 price target.
24 September 2025
···
Alibaba Stock Skyrockets on AI Breakthrough – Key Facts & Latest 2025 Update

Alibaba Stock Skyrockets on $53B AI Push – Hits 4-Year High, Experts Bullish

Alibaba shares surged nearly 10% to about $177 on September 24, 2025, hitting a four-year high after the company announced a $53 billion AI investment and new partnerships with Nvidia. The company unveiled its most advanced AI model, Qwen3-Max, and reported 26% year-on-year cloud revenue growth for the June quarter. Wall Street raised price targets, with Bank of America and Barclays citing strong AI prospects.
24 September 2025
···
uniQure (QURE) Stock Soars on Huntington’s Breakthrough – Key Facts & 2025 Outlook

uniQure (QURE) Stock Soars on Huntington’s Breakthrough – Key Facts & 2025 Outlook

uniQure reported its gene therapy AMT-130 slowed Huntington’s disease progression by 75% over three years in high-dose patients. Trading in QURE shares was halted on volatility; the stock jumped from $4.45 to the mid-teens. The company secured a $175 million loan to fund AMT-130’s potential launch. Wall Street analysts rate the stock “Buy,” with targets averaging $37–$40.
24 September 2025
···
1 … 1,301 1,302 1,303 1,304 1,305 … 1,318
Go toTop